NEWS

For our visitors who seek the latest industry news and updates to keep up with the goings-on of the business on a global scale, this portal grants a dynamic and diverse feed of news items contemporaneous with the current affairs of the Pharmaceutical Industry.

news

Drug firm CiplaBSE 2.00 % today said it has received final approval from the American health regulator to market Entecavir tablets used for treatment of Hepatitis B infection. In a BSE filing, Cipla said "it has received final approval for its abbreviated new drug application (ANDA) for Entecavir tablets USP…

news

Britain's competition watchdog has fined Pfizer (PFE.N) a record 84.2 million pounds ($107 million) for its role in ramping up the cost of an epilepsy drug by as much as 2,600 percent. The Competition and Markets Authority (CMA) also fined Flynn Pharma 5.2 million pounds for overcharging for phenytoin sodium…

news

H2-Pharma, LLC announced today that it has acquired the exclusive rights to distribute fifteen (15) products from Mayne Pharma, Inc. In 2015 the combined market for these products was approximately $8.3 million according to IMS Health.  H2-Pharma has already launched three (3) of these products and will launch the remaining…

news

 Presents positive 1-year follow-up data of its pivotal Phase II Trial with ATIR101  Significant reduction in Transplant Related Mortality and improvement in Overall Survival observed in comparison to an observational control group   Zero patients developed grade III-IV acute Graft-versus-Host-Disease upon infusion of ATIR101   Source:reuters.com

news

Pharma major LupinBSE -0.56 % today said it has received tentative approval for its generic version of Diclofenac capsules, used in pain management of osteoarthritis, from US health regulator USFDA. The approval is for multiple strengths of 18 mg and 35 mg, a company statement said. Lupins Diclofenac capsules are…

news

The Ministry of Health (MoH) has granted 12 companies medical permits to build pharmaceutical factories in collaboration with the Public Authority for Industry (PAI), a health official said yesterday. Speaking on the sidelines of a GCC drug registration meeting, Assistant Undersecretary of Pharmaceutical and Medical Necessities Affairs Dr Amr Al-Sayid…

news

The European Medicines Agency warned on Friday that some of the most successful hepatitis C treatments on the market could reactivate hepatitis B in patients, the second time this year it has raised safety concerns over these treatments. The latest health warning covers some of the top-selling products in the…

news

In the United States, cancer drugs are sometimes approved through sped-up processes - and they often stay approved even if later studies show them to be inferior to other options or even worse than doing nothing, a new study found. Researchers evaluated studies done on 18 cancer drugs approved between…

news

Uni-bio Science Group Ltd unit entered into a multiple drug co-development agreement with Beijing Sun-Novo Pharmaceutical Research Co., Limited. deal to extend group's current research and development capabilities in small molecule drug development. Project is targeted to start in 2017 and launch sales in market around 2020-2021.   Source :…

news

Pharma major Lupin today announced a new partnership with Eli Lilly India to market and sell the latter's diabetes treatment drug 'Eglucent' in the country. "According to the agreement, Lupin will market and sell Eglucent through its own specialty field force while Lilly will be responsible for manufacturing and import,"…